Author(s):
Vitthal B. Kundgir, Chandrashekhar D. Patil, Kajal V. Pansare, Jubershaha S. Fakir, Durgesh S. Pagar, Sharwari K. Sonawane, Sunil K. Mahajan
Email(s):
vitthalkundgir357@gmail.com
DOI:
10.52711/2321-5836.2026.00043 
Address:
Vitthal B. Kundgir1*, Chandrashekhar D. Patil1, Kajal V. Pansare1, Jubershaha S. Fakir1, Durgesh S. Pagar1 , Sharwari K. Sonawane3, Sunil K. Mahajan2
1Department of Pharmacology, Shreeshakti Shakshanik Sanstha, Divine College of Pharmacy Nampur Road Satana, Nashik - 423301, Maharashtra, India.
2Department of pharmaceutical chemistry, Shreeshakti Shakshanik Sanstha, Divine College of Pharmacy Nampur Road Satana, Nashik - 423301, Maharashtra, India.
3Department of Pharmaceutics, Shreeshakti Shakshanik Sanstha, Divine College of Pharmacy Nampur Road Satana, Nashik - 423301, Maharashtra, India.
*Corresponding Author
Published In:
Volume - 18,
Issue - 3,
Year - 2026
ABSTRACT:
Urolithiasis is a common and highly recurrent urinary tract disorder characterized by the formation of crystalline calculi within the renal system. Although contemporary interventions such as surgical stone removal and pharmacological prophylaxis are effective in acute management, recurrence rates remain high due to the multifactorial pathogenesis of the disease and limitations of long-term preventive therapies. Consequently, increasing attention has been directed toward phytotherapeutic agents possessing multi-target pharmacological actions. This review critically examines the mechanistic rationale, preclinical evidence, and translational potential of Tribulus terrestris, Bryophyllum pinnatum, and citrate-rich botanicals as preventive or adjunctive strategies for recurrent urolithiasis. Relevant literature published between 2000 and 2026 was evaluated from major scientific databases including PubMed, Scopus, and Web of Science. Current evidence indicates that recurrent stone disease is driven by urinary supersaturation, crystal nucleation, oxidative epithelial injury, inflammation, and impaired endogenous inhibitory mechanisms. Tribulus terrestris demonstrates diuretic, crystal-growth inhibitory, and urinary biochemical modulating effects, primarily attributed to steroidal saponins and flavonoids. Bryophyllum pinnatum exhibits antioxidant, nephroprotective, and anti-adhesion activities that may reduce tubular injury and crystal retention. Citrate-rich botanicals, particularly Citrus sinensis derivatives, enhance urinary citrate, chelate calcium ions, and promote urinary alkalinization, thereby limiting calcium stone formation. Collectively, these agents target complementary stages of lithogenesis and may offer value in recurrence prevention. However, rigorous randomized clinical trials, pharmacokinetic characterization, and standardized formulations remain necessary before routine clinical application.
Cite this article:
Vitthal B. Kundgir, Chandrashekhar D. Patil, Kajal V. Pansare, Jubershaha S. Fakir, Durgesh S. Pagar, Sharwari K. Sonawane, Sunil K. Mahajan. Targeting Kidney Stone Recurrence with Multi-Mechanistic Phytotherapeutics: Translational Promise of Tribulus terrestris, Bryophyllum pinnatum and Citrate-Rich Botanicals. Research Journal of Pharmacology and Pharmacodynamics.2026;18(3):313-4. doi: 10.52711/2321-5836.2026.00043
Cite(Electronic):
Vitthal B. Kundgir, Chandrashekhar D. Patil, Kajal V. Pansare, Jubershaha S. Fakir, Durgesh S. Pagar, Sharwari K. Sonawane, Sunil K. Mahajan. Targeting Kidney Stone Recurrence with Multi-Mechanistic Phytotherapeutics: Translational Promise of Tribulus terrestris, Bryophyllum pinnatum and Citrate-Rich Botanicals. Research Journal of Pharmacology and Pharmacodynamics.2026;18(3):313-4. doi: 10.52711/2321-5836.2026.00043 Available on: https://www.rjppd.org/AbstractView.aspx?PID=2026-18-3-14
14. REFERENCE:
1. Sorokin I, Mamoulakis C, Miyazawa K, Rodgers A, Talati J, Lotan Y. Epidemiology of stone disease across the world. World Journal of Urology. 2017 Sep; 35(9):1301-20.
2. Worcester EM, Coe FL. Calcium kidney stones. New England Journal of Medicine. 2010 Sep 2; 363(10): 954-63.
3. Pearle MS, Goldfarb DS, Assimos DG, Curhan G, Denu-Ciocca CJ, Matlaga BR, Monga M, Penniston KL, Preminger GM, Turk TM, White JR. Medical management of kidney stones: AUA guideline. The Journal of Urology. 2014 Aug; 192(2): 316-24.
4. Aggarwal A, Tandon S, Singla SK, Tandon C. Diminution of oxalate induced renal tubular epithelial cell injury and inhibition of calcium oxalate crystallization in vitro by aqueous extract of Tribulus terrestris. International Braz J Urol. 2010; 36: 480-9.
5. Patel PK, Patel MA, Vyas BA, Shah DR, Gandhi TR. Antiurolithiatic activity of saponin rich fraction from the fruits of Solanum xanthocarpum Schrad. & Wendl.(Solanaceae) against ethylene glycol induced urolithiasis in rats. Journal of Ethnopharmacology. 2012 Oct 31; 144(1): 160-70.
6. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009 Jul 21; 339.
7. Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, Chou R. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021 Mar 29; 372.
8. Khan SR, Canales BK, Dominguez-Gutierrez PR. Randall’s plaque and calcium oxalate stone formation: role for immunity and inflammation. Nature Reviews Nephrology. 2021 Jun; 17(6): 417-33.
9. Robertson WG. Kidney models of calcium oxalate stone formation. Nephron Physiology. 2004 Oct 1; 98(2): 21-30.
10. Evan A, Lingeman J, Coe FL, Worcester E. Randall's plaque: pathogenesis and role in calcium oxalate nephrolithiasis. Kidney International. 2006 Apr 2; 69(8):1313-8.
11. Verkoelen CF, Van Der Boom BG, Houtsmuller AB, Schröder FH, Romijn JC. Increased calcium oxalate monohydrate crystal binding to injured renal tubular epithelial cells in culture. American Journal of Physiology-Renal Physiology. 1998 May 1; 274(5): F958-65.
12. Thamilselvan S, Hackett RL, Khan SR. Lipid peroxidation in ethylene glycol induced hyperoxaluria and calcium oxalate nephrolithiasis. The Journal of Urology. 1997 Mar; 157(3): 1059-63.
13. Mulay SR, Evan A, Anders HJ. Molecular mechanisms of crystal-related kidney inflammation and injury. Implications for cholesterol embolism, crystalline nephropathies and kidney stone disease. Nephrology Dialysis Transplantation. 2014 Mar 1; 29(3): 507-14.
14. Barr-Beare E, Saxena V, Hilt EE, Thomas-White K, Schober M, Li B, Becknell B, Hains DS, Wolfe AJ, Schwaderer AL. The interaction between Enterobacteriaceae and calcium oxalate deposits. PloS One. 2015 Oct 8; 10(10): e0139575.
15. Ferraro PM, Taylor EN, Gambaro G, Curhan GC. Dietary and lifestyle risk factors associated with incident kidney stones in men and W Türk C, Knoll T, Petrik A, Sarica K, Straub M, Seitz C. Guidelines on urolithiasis. European Association of Urology. 2011 Mar 30.
16. Osman MM, Alfano Y, Kamp S, Haecker A, Alken P, Michel MS, Knoll T. 5-year-follow-up of patients with clinically insignificant residual fragments after extracorporeal shockwave lithotripsy. European Urology. 2005 Jun 1; 47(6): 860-4.
17. Fink HA, Wilt TJ, Eidman KE, Garimella PS, MacDonald R, Rutks IR, Brasure M, Kane RL, Monga M. Recurrent nephrolithiasis in adults: comparative effectiveness of preventive medical strategies.
18. Butterweck V, Khan SR. Herbal medicines in the management of urolithiasis: alternative or complementary?. Planta Medica. 2009 Aug; 75(10): 1095-103.
19. Aggarwal A, Tandon S, Singla SK, Tandon C. Diminution of oxalate induced renal tubular epithelial cell injury and inhibition of calcium oxalate crystallization in vitro by aqueous extract of Tribulus terrestris. International Braz J Urol. 2010; 36: 480-9.
20. Chhatre S, Nesari T, Somani G, Kanchan D, Sathaye S. Phytopharmacological overview of Tribulus terrestris. Pharmacognosy Reviews. 2014 Jan; 8(15):45.
21. Anand R, Patnaik GK, Kulshreshtha DK, Dhawan BN. Activity of certain fractions of Tribulus terrestris fruits against experimentally induced urolithiasis in rats. Indian Journal of Experimental Biology. 1994 Aug 1; 32(8): 548-52.
22. Kaushik J, Tandon S, Bhardwaj R, Kaur T, Singla SK, Kumar J, Tandon C. Delving into the Antiurolithiatic potential of Tribulus terrestris extract through–In Vivo Efficacy and Preclinical Safety investigations in Wistar Rats. Scientific Reports. 2019 Nov 4; 9(1): 15969.
23. Prasad AK, Kumar S, Iyer SV, Sudani RJ, Vaidya SK. Pharmacognostical, phytochemical and pharmacological review on Bryophyllum pinnata. International Journal of Pharmaceutical and Biological Archives. 2012 Oct 24; 3(3): 423-33.
24. Ojewole JA. Antinociceptive, anti-inflammatory and antidiabetic effects of Bryophyllum pinnatum (Crassulaceae) leaf aqueous extract. Journal of Ethnopharmacology. 2005 May 13; 99(1): 13-9.
25. Prudente AS, Loddi AM, Duarte MR, Santos AR, Pochapski MT, Pizzolatti MG, Hayashi SS, Campos FR, Pontarolo R, Santos FA, Cabrini DA. Pre-clinical anti-inflammatory aspects of a cuisine and medicinal.
26. Atmani F, Khan SR. Effects of an extract from Herniaria hirsuta on calcium oxalate crystallization in vitro. BJU International. 2000 Apr; 85(6): 621-5.
27. García-Pérez P, Lozano-Milo E, Landin M, Gallego PP. From ethnomedicine to plant biotechnology and machine learning: the valorization of the medicinal plant Bryophyllum sp. Pharmaceuticals. 2020 Dec 4; 13(12): 444.
28. Fürer K, Simões-Wüst AP, von Mandach U, Hamburger M, Potterat O. Bryophyllum pinnatum and related species used in anthroposophic medicine: constituents, pharmacological activities, and clinical efficacy. Planta Medica. 2016 Jul; 82(11/12): 930-41.
29. Odvina CV. Comparative value of orange juice versus lemonade in reducing stone-forming risk. Clinical Journal of the American Society of Nephrology. 2006 Nov 1; 1(6): 1269-74.
30. Seltzer MA, Low RK, McDonald M, Shami GS, Stoller ML. Dietary manipulation with lemonade to treat hypocitraturic calcium nephrolithiasis. The Journal of Urology. 1996 Sep; 156(3): 907-9.
31. Rosen RC, Catania JA, Althof SE, Pollack LM, O’Leary M, Seftel AD, Coon DW. Development and validation of four-item version of Male Sexual Health Questionnaire to assess ejaculatory dysfunction. Urology. 2007 May 1; 69(5): 805-9.
32. Aggarwal A, Tandon S, Singla SK, Tandon C. Diminution of oxalate-induced renal tubular epithelial cell injury and inhibition of calcium oxalate crystal deposition in experimental nephrolithiasis by Tribulus terrestris extract. Urol Res. 2010; 38(5): 379-384. doi:10.1007/s00240-010-0290-y.
33. Semalty A, Semalty M, Rawat MS, Franceschi F. Supramolecular phospholipids–polyphenolics interactions: The Phytosome® strategy to improve the bioavailability of phytochemicals. Fitoterapia. 2010 Jul 1; 81(5): 306-14.